Company: HUM
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000049071-25-000007
Chunk: 7

Company: HUMANA INC
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 7
---
 70 Net cash provided by operating activities2,966 3,981 4,587 Cash flows from investing activitiesProceeds from sale of Gentiva Hospice, net— — 2,701 Acquisitions, net of cash and cash equivalents acquired(89)(233)(337)Purchases of property and equipment(575)(1,004)(1,137)Proceeds from sale of property and equipment7 210 17 Changes in securities lending collateral receivable(418)— — Purchases of investment securities(8,185)(7,552)(6,049)Proceeds from maturities of investment securities2,982 1,292 1,365 Proceeds from sales of investment securities3,376 3,795 2,434 Other(50)— — Net cash used in investing activities(2,952)(3,492)(1,006)Cash flows from financing activities(Payments) receipts from contract deposits, net(1,933)828 1,993 Proceeds from issuance of senior notes, net2,232 2,544 1,982 Repayment of senior notes(1,107)(1,832)(1,000)(Repayments) proceeds from issuance of commercial paper, net(907)211 (376)Proceeds from short-term borrowings— 100 — Repayment of short-term borrowings— (100)— Repayment of term loan— (500)(2,000)Debt issue costs(7)(7)(6)Common stock repurchases(817)(1,573)(2,096)Dividends paid(431)(431)(392)Changes in securities lending payable418 — — Changes in rebate factor payable123 — — Change in book overdraft50 55 (28)Other, net(108)(151)9 Net cash used in financing activities(2,487)(856)(1,914)(Decrease) increase in cash and cash equivalents(2,473)(367)1,667 Cash and cash equivalents at beginning of period4,694 5,061 3,394 Cash and cash equivalents at end of period$2,221 $4,694 $5,061 

70

Humana Inc.

CONSOLIDATED STATEMENTS OF CASH FLOW—(Continued)

For the year ended December 31,202420232022Supplemental